NASDAQFinancialsBanks - RegionalSnapshot 2026-08-31
Reading HBAN? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →Intact: The reason to own it still holds.
Huntington grows revenue fast, up 34% year over year in Q1. It keeps paying a steady dividend of $0.155 per share. New tech helps it win more customers. Operating leverage is improving, which should boost profits.
Growth may slow below analyst expectations near 9%. Litigation risks could hurt costs and reputation. Dividend might be cut if earnings weaken.
The price is about 7% above our fair value near $17. Analysts expect about 9% revenue growth, which matches our view.
Breaks if: Quarterly dividend falls below $0.155 per share
Breaks if: Operating leverage fails to improve or worsens in FY26
YoY revenue growth falls below 8% in FY26
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a durable compounder with a focus on organic growth and strategic acquisitions. The current thesis state is cautious, as recent performance has improved but remains under watch due to potential volatility in management execution.
The market appears to have priced in a neutral valuation, with HBAN being viewed as cheap compared to its peers. There is a slight expectations gap, indicating that investors may not fully anticipate the potential for improved performance.
Fundamentals are likely to remain stable, with management focused on driving organic growth and maintaining dividends. However, there is a moderate risk of missing earnings expectations, given the company's recent history of misses.
The thesis hinges on the performance of sector bellwethers like HDB, IBN, and PNC. If these companies continue to perform well, it could provide a favorable environment for HBAN. Conversely, any negative guidance from these peers could impact HBAN's momentum.
The most important moves since the prior daily snapshot.
Mixed, the news cuts both ways. The company provided details on achieving its ROTCE target. This aligns with growth objectives and supports the thesis. However, mixed credit signals indicate potential growth challenges.
as of 2026-08-31
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
In the next 1 to 3 years, HBAN's performance will depend on management's execution and the broader financial sector's health. Not investment advice.
